Cited by 5Clinical practice guidelines implementationHealth Policy Implementation ScienceAntiplatelet Therapy and Cardiovascular Diseases

Reconsidering low-dose aspirin therapy for cardiovascular disease: a study protocol for physician and patient behavioral change

Open access
Folks, Brittany, LeBlanc, William G, Staton, Elizabeth W, Pace, Wilson D·2011·Implementation Science

Abstract

Background: There are often disparities between current evidence and current practice. Decreasing the gap between desired practice outcomes and observed practice outcomes in the healthcare system is not always easy. Stopping previously recommended or variably recommended interventions may be even harder to achieve than increasing the use of a desired but under-performed activity. For over a decade, aspirin has been prescribed for primary prevention of cardiovascular disease and for patients with the coronary artery disease risk equivalents; yet, there is no substantial evidence of an appropriate risk-benefit ratio to support this practice. This paper describes the protocol of a randomized trial being conducted in six primary care practices in the Denver metropolitan area to examine the effectiveness of three interventional strategies to change physician behavior regarding prescription of low-dose aspirin. Methods: All practices received academic detailing, one arm received clinician reminders to reconsider aspirin, a second arm received both clinician and patient messages to reconsider aspirin. The intervention will run for 15 to 18 months. Data collected at baseline and for outcomes from an electronic health record will be used to assess pre- and post-interventional prescribing, as well as to explore any inappropriate decrease in aspirin use by patients with known cardiovascular disease. Discussion: This study was designed to investigate effective methods of changing physician behavior to decrease the use of aspirin for primary cardiovascular disease prevention. The results of this study will contribute to the small pool of knowledge currently available on the topic of ceasing previously supported practices. Trial Registration: ClinicalTrials.gov: NCT01247454

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1748-5908-6-65

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Across diverse fields, reasonable consensus has developed about when particular designs should be used and what sample size and design protocols are needed to maximize internal validity.

    “Within this growing family of randomized, nonrandomized, and mixed method designs, reasonable consensus has grown across diverse fields about when certain designs should be used and what sample size requirements and design protocols are necessary to maximize internal validity (42, 87).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 42 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Folks, B., LeBlanc, W. G., Staton, E. W., & Pace, W. D.
Affiliations
University of Colorado Denver (US)
Corresponding author
Staton, Elizabeth W
Venue
Implementation Science
Published
2011-06-26
Volume
6
Issue
1
Pages
65-65
ISSN
1748-5908 (ISSN-L)
OpenAlex
W2163363279
Cited by
5
References
42
Citations by year
2026: 1 · 2022: 1 · 2017: 1 · 2014: 2
FWCI
0.63
Type
journal article
Language
en
Open access
Locations
  • Implementation Science (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Keywords
low-dose aspirin, aspirin prescribing, primary prevention of cardiovascular disease, physician behavior change, academic detailing, knowledge-practice gap, primary care, electronic health records
MeSH terms
Aspirin, Cardiovascular Diseases, Clinical Protocols, Colorado, Coronary Artery Disease, Decision Support Techniques, Education, Medical, Continuing, Humans, Practice Patterns, Physicians'

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review